TenecteplaseAlteplaseTNKtPA
… thrombolytic administered within 4.5 hours of stroke symptoms. Tenecteplase (TNK) is FDA-approved for STEMI, but its off-label use for AIS …
7articles mentioning drugs
30drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: tPA ×
tPA
This drug is selected. Its supporting articles are shown below.
Articles mentioning tPA
7 articles · page 1 of 1TNKalteplasetPATenecteplaseperipheral vascular disease
…, and functional dependency (28.1% vs 22.8%, p=0.37).Conclusion TNK and tPA demonstrated comparable safety and mortality in BAO tre…
tPAthrombolysisacute ischemic stroke (AIS)
…telets, and white blood cells (WBCs). Clot fragments exposed to tPA were analyzed after 3.5 hours. Fragments from the same clot tha…
urokinasetissue plasminogen activator (tPA)tPAchronic subdural hematomaChronic subdural hematoma (cSDH)The Segal Family FoundationSegal Family Internship in Cerebrovascular MedicinecSDHresidual hematoma
…th no consensus regarding optimal management. Adjunctive use of urokinase has been suggested to reduce recurrence rates and minimize post…
tPAtissue plasminogen activatorNIH Stroke ScaleAISNIHSS
…lusion (LVO) and non-LVO AIS, and tissue plasminogen activator (tPA) and EST use.Results Among 20 317 AIS admissions, median age wa…
tPATNKtandem occlusionsintravenous thrombolysisextracranial internal carotid artery (ICA) disease
…. A total of 87.5% of patients received TNK, and 12.5% received tPA.Acute CAS was performed in 58.3% of cases. A retrograde (intrac…